Concepts (210)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nevus, Pigmented | 22 | 2023 | 50 | 3.420 |
Why?
|
| Skin Neoplasms | 29 | 2023 | 580 | 2.540 |
Why?
|
| Ear, External | 5 | 2011 | 26 | 1.070 |
Why?
|
| Surgical Flaps | 18 | 2009 | 249 | 1.040 |
Why?
|
| Tissue Expansion | 12 | 2009 | 19 | 0.990 |
Why?
|
| Facial Neoplasms | 4 | 2009 | 25 | 0.610 |
Why?
|
| Ear Deformities, Acquired | 3 | 2011 | 3 | 0.540 |
Why?
|
| Skin Transplantation | 9 | 2018 | 184 | 0.480 |
Why?
|
| Infant | 30 | 2021 | 3160 | 0.480 |
Why?
|
| Child, Preschool | 25 | 2021 | 3731 | 0.480 |
Why?
|
| Child | 28 | 2021 | 7174 | 0.470 |
Why?
|
| Cicatrix, Hypertrophic | 1 | 2011 | 8 | 0.390 |
Why?
|
| Ear Auricle | 1 | 2009 | 2 | 0.350 |
Why?
|
| Eyelid Neoplasms | 1 | 2009 | 6 | 0.350 |
Why?
|
| Facial Muscles | 3 | 2003 | 23 | 0.340 |
Why?
|
| Ear Cartilage | 3 | 2009 | 4 | 0.320 |
Why?
|
| Leg | 2 | 2009 | 140 | 0.320 |
Why?
|
| Surgery, Plastic | 5 | 1990 | 42 | 0.290 |
Why?
|
| Cicatrix | 4 | 2021 | 68 | 0.280 |
Why?
|
| Macrostomia | 2 | 2002 | 2 | 0.260 |
Why?
|
| Humans | 62 | 2023 | 89357 | 0.260 |
Why?
|
| Upper Extremity | 1 | 2005 | 52 | 0.250 |
Why?
|
| Lower Extremity | 1 | 2005 | 88 | 0.240 |
Why?
|
| Esthetics | 4 | 2009 | 45 | 0.240 |
Why?
|
| Nevus | 3 | 2009 | 15 | 0.240 |
Why?
|
| Skin Diseases | 2 | 2001 | 173 | 0.230 |
Why?
|
| Mandibular Advancement | 1 | 2003 | 6 | 0.230 |
Why?
|
| Facial Asymmetry | 1 | 2003 | 12 | 0.230 |
Why?
|
| Micrognathism | 1 | 2003 | 11 | 0.230 |
Why?
|
| Osteogenesis, Distraction | 1 | 2003 | 24 | 0.220 |
Why?
|
| Xanthogranuloma, Juvenile | 1 | 2003 | 3 | 0.220 |
Why?
|
| Absorbable Implants | 1 | 2003 | 35 | 0.220 |
Why?
|
| Tissue Expansion Devices | 4 | 2009 | 8 | 0.200 |
Why?
|
| Scalp | 4 | 2004 | 72 | 0.190 |
Why?
|
| Hamartoma | 1 | 2001 | 34 | 0.190 |
Why?
|
| Neurilemmoma | 1 | 2021 | 34 | 0.190 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2021 | 92 | 0.190 |
Why?
|
| Cleft Lip | 4 | 1984 | 15 | 0.180 |
Why?
|
| Male | 32 | 2021 | 42411 | 0.180 |
Why?
|
| Lymphangioma | 2 | 1994 | 15 | 0.170 |
Why?
|
| Female | 31 | 2018 | 46202 | 0.160 |
Why?
|
| Melanoma | 3 | 2015 | 468 | 0.160 |
Why?
|
| Skin | 5 | 2016 | 582 | 0.160 |
Why?
|
| GTP Phosphohydrolases | 2 | 2015 | 74 | 0.150 |
Why?
|
| Free Tissue Flaps | 1 | 2018 | 49 | 0.150 |
Why?
|
| Postoperative Complications | 6 | 2011 | 2284 | 0.150 |
Why?
|
| Hand | 2 | 2004 | 133 | 0.150 |
Why?
|
| Neoadjuvant Therapy | 1 | 2021 | 377 | 0.150 |
Why?
|
| Adolescent | 13 | 2014 | 9263 | 0.150 |
Why?
|
| Neuroectodermal Tumors, Primitive | 1 | 1997 | 9 | 0.150 |
Why?
|
| Cleft Palate | 3 | 1988 | 26 | 0.150 |
Why?
|
| Eczema | 1 | 2016 | 7 | 0.140 |
Why?
|
| Contracture | 2 | 2008 | 18 | 0.140 |
Why?
|
| Scrotum | 2 | 2007 | 18 | 0.140 |
Why?
|
| Dermatitis, Atopic | 1 | 2016 | 55 | 0.130 |
Why?
|
| Th17 Cells | 1 | 2016 | 85 | 0.130 |
Why?
|
| Th2 Cells | 1 | 2016 | 147 | 0.130 |
Why?
|
| Spheroids, Cellular | 1 | 2015 | 31 | 0.130 |
Why?
|
| Syndactyly | 1 | 1994 | 12 | 0.120 |
Why?
|
| Cartilage | 4 | 2009 | 116 | 0.120 |
Why?
|
| Skin Diseases, Vesiculobullous | 1 | 1994 | 18 | 0.120 |
Why?
|
| Benzimidazoles | 1 | 2015 | 111 | 0.120 |
Why?
|
| Genital Neoplasms, Male | 1 | 1994 | 11 | 0.120 |
Why?
|
| Mast Cells | 1 | 2014 | 94 | 0.120 |
Why?
|
| Burns | 2 | 1993 | 141 | 0.110 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2014 | 146 | 0.110 |
Why?
|
| Mouth | 2 | 1984 | 48 | 0.110 |
Why?
|
| Rhinoplasty | 3 | 2003 | 35 | 0.110 |
Why?
|
| Treatment Outcome | 6 | 2023 | 8241 | 0.110 |
Why?
|
| Psoriasis | 1 | 2016 | 245 | 0.110 |
Why?
|
| Transcription Factors | 1 | 2021 | 1653 | 0.110 |
Why?
|
| Sweat Gland Neoplasms | 1 | 1992 | 7 | 0.110 |
Why?
|
| Membrane Proteins | 2 | 2015 | 1224 | 0.100 |
Why?
|
| Graft Survival | 2 | 2018 | 900 | 0.100 |
Why?
|
| Bone Transplantation | 2 | 2018 | 66 | 0.090 |
Why?
|
| Brain Neoplasms | 2 | 2015 | 782 | 0.090 |
Why?
|
| Follow-Up Studies | 3 | 2009 | 3666 | 0.090 |
Why?
|
| Muscles | 2 | 1988 | 193 | 0.090 |
Why?
|
| Adult | 9 | 2021 | 26607 | 0.080 |
Why?
|
| Rare Diseases | 1 | 2009 | 70 | 0.080 |
Why?
|
| Algorithms | 3 | 2008 | 1877 | 0.080 |
Why?
|
| Palatal Muscles | 1 | 1988 | 1 | 0.080 |
Why?
|
| Velopharyngeal Insufficiency | 1 | 1988 | 3 | 0.080 |
Why?
|
| Palate | 1 | 1988 | 6 | 0.080 |
Why?
|
| Prosthesis-Related Infections | 1 | 2009 | 61 | 0.080 |
Why?
|
| Reoperation | 2 | 2008 | 599 | 0.080 |
Why?
|
| Apoptosis | 1 | 2015 | 1717 | 0.080 |
Why?
|
| Extremities | 3 | 2004 | 169 | 0.080 |
Why?
|
| Connective Tissue | 1 | 1988 | 23 | 0.080 |
Why?
|
| Dermatologic Surgical Procedures | 1 | 1988 | 16 | 0.080 |
Why?
|
| Head and Neck Neoplasms | 2 | 2001 | 1063 | 0.080 |
Why?
|
| Epidermis | 1 | 1988 | 102 | 0.070 |
Why?
|
| Hypospadias | 1 | 2007 | 6 | 0.070 |
Why?
|
| Adipose Tissue | 1 | 2009 | 259 | 0.070 |
Why?
|
| Retrospective Studies | 3 | 2009 | 9057 | 0.070 |
Why?
|
| Nose | 3 | 1989 | 94 | 0.070 |
Why?
|
| Mutation | 2 | 2015 | 4143 | 0.070 |
Why?
|
| Cysts | 1 | 1987 | 106 | 0.070 |
Why?
|
| Abdominal Muscles | 1 | 2005 | 19 | 0.070 |
Why?
|
| Wound Healing | 1 | 2008 | 359 | 0.060 |
Why?
|
| Pediatrics | 1 | 1990 | 353 | 0.060 |
Why?
|
| Methods | 3 | 1994 | 151 | 0.060 |
Why?
|
| Forehead | 2 | 2002 | 15 | 0.060 |
Why?
|
| Cell Proliferation | 3 | 2015 | 1652 | 0.060 |
Why?
|
| Risk Assessment | 2 | 2009 | 2303 | 0.060 |
Why?
|
| Nasal Septum | 1 | 2003 | 28 | 0.060 |
Why?
|
| Graft Rejection | 1 | 2009 | 1070 | 0.060 |
Why?
|
| Cheek | 1 | 2023 | 22 | 0.060 |
Why?
|
| Neck | 1 | 2004 | 104 | 0.060 |
Why?
|
| Face | 1 | 2004 | 116 | 0.060 |
Why?
|
| Dermatofibrosarcoma | 1 | 2003 | 13 | 0.050 |
Why?
|
| Cartilage Diseases | 1 | 2003 | 18 | 0.050 |
Why?
|
| Blotting, Western | 2 | 2015 | 794 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2009 | 2872 | 0.050 |
Why?
|
| Rhabdomyosarcoma, Alveolar | 1 | 2002 | 4 | 0.050 |
Why?
|
| Hypertrophy | 1 | 2002 | 67 | 0.050 |
Why?
|
| Pseudomonas Infections | 1 | 2003 | 99 | 0.050 |
Why?
|
| Mandible | 1 | 2003 | 120 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2003 | 153 | 0.050 |
Why?
|
| Suture Techniques | 1 | 2002 | 140 | 0.050 |
Why?
|
| Age Factors | 3 | 2016 | 1870 | 0.050 |
Why?
|
| Syndrome | 3 | 2003 | 449 | 0.050 |
Why?
|
| Prostheses and Implants | 4 | 1989 | 124 | 0.050 |
Why?
|
| Epidermal Cyst | 1 | 1980 | 7 | 0.050 |
Why?
|
| Cell Death | 1 | 2021 | 262 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2023 | 856 | 0.040 |
Why?
|
| Family | 1 | 2021 | 325 | 0.040 |
Why?
|
| Infant, Newborn | 5 | 1992 | 2486 | 0.040 |
Why?
|
| Perineum | 2 | 2002 | 36 | 0.040 |
Why?
|
| Melanocytes | 2 | 2014 | 57 | 0.040 |
Why?
|
| Dermoid Cyst | 2 | 1988 | 15 | 0.040 |
Why?
|
| Nose Neoplasms | 2 | 1988 | 31 | 0.040 |
Why?
|
| Activities of Daily Living | 1 | 2018 | 207 | 0.040 |
Why?
|
| Immunohistochemistry | 3 | 2014 | 1799 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2015 | 4289 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2003 | 1365 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 1714 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 306 | 0.030 |
Why?
|
| Neurocutaneous Syndromes | 1 | 2014 | 12 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 323 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2021 | 1525 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2015 | 1057 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1980 | 1096 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2014 | 529 | 0.030 |
Why?
|
| Buttocks | 1 | 1992 | 10 | 0.030 |
Why?
|
| Thigh | 1 | 1992 | 39 | 0.030 |
Why?
|
| Cytokines | 1 | 2016 | 803 | 0.030 |
Why?
|
| Craniofacial Dysostosis | 1 | 1991 | 12 | 0.030 |
Why?
|
| Limb Deformities, Congenital | 1 | 1991 | 20 | 0.020 |
Why?
|
| Anesthesia, Inhalation | 1 | 1991 | 36 | 0.020 |
Why?
|
| Soft Tissue Neoplasms | 1 | 1992 | 128 | 0.020 |
Why?
|
| Quality of Life | 1 | 2018 | 1668 | 0.020 |
Why?
|
| Genotype | 1 | 2014 | 1849 | 0.020 |
Why?
|
| Mandibular Fractures | 1 | 1989 | 7 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 1994 | 1597 | 0.020 |
Why?
|
| Speech Articulation Tests | 1 | 1988 | 1 | 0.020 |
Why?
|
| Speech Disorders | 1 | 1988 | 19 | 0.020 |
Why?
|
| Otitis Media | 1 | 1988 | 20 | 0.020 |
Why?
|
| Airway Obstruction | 1 | 1989 | 111 | 0.020 |
Why?
|
| Catheterization | 1 | 1989 | 237 | 0.020 |
Why?
|
| Body Surface Area | 1 | 1988 | 36 | 0.020 |
Why?
|
| Skin Physiological Phenomena | 1 | 1988 | 27 | 0.020 |
Why?
|
| Phenotype | 1 | 2014 | 2440 | 0.020 |
Why?
|
| Fibroma | 1 | 1988 | 33 | 0.020 |
Why?
|
| Penis | 1 | 2007 | 60 | 0.020 |
Why?
|
| Swine | 1 | 1988 | 582 | 0.020 |
Why?
|
| Collagen | 1 | 1988 | 293 | 0.020 |
Why?
|
| Fistula | 1 | 1986 | 42 | 0.020 |
Why?
|
| Recurrence | 1 | 1988 | 1144 | 0.020 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 1984 | 10 | 0.020 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 1984 | 15 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2015 | 3385 | 0.010 |
Why?
|
| Histological Techniques | 1 | 1984 | 36 | 0.010 |
Why?
|
| Radiography | 2 | 1986 | 809 | 0.010 |
Why?
|
| Leiomyoma | 1 | 1988 | 202 | 0.010 |
Why?
|
| United States | 1 | 2016 | 6989 | 0.010 |
Why?
|
| Angiography | 1 | 1984 | 208 | 0.010 |
Why?
|
| Aged | 2 | 2016 | 19165 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2003 | 72 | 0.010 |
Why?
|
| Mohs Surgery | 1 | 2003 | 24 | 0.010 |
Why?
|
| Maxillofacial Development | 1 | 1982 | 4 | 0.010 |
Why?
|
| Malocclusion | 1 | 1982 | 7 | 0.010 |
Why?
|
| Orthodontic Appliances | 1 | 1982 | 7 | 0.010 |
Why?
|
| Cephalometry | 1 | 1982 | 50 | 0.010 |
Why?
|
| Maxilla | 1 | 1982 | 19 | 0.010 |
Why?
|
| Contraindications | 1 | 2002 | 70 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2003 | 233 | 0.010 |
Why?
|
| Postoperative Care | 1 | 2003 | 231 | 0.010 |
Why?
|
| Models, Biological | 1 | 1988 | 1765 | 0.010 |
Why?
|
| Surgical Procedures, Operative | 1 | 2003 | 206 | 0.010 |
Why?
|
| Precancerous Conditions | 1 | 1980 | 200 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 1982 | 1072 | 0.010 |
Why?
|
| Middle Aged | 1 | 2016 | 25974 | 0.010 |
Why?
|
| Organelles | 1 | 1994 | 56 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1994 | 511 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 1994 | 599 | 0.010 |
Why?
|
| Neurofibroma | 1 | 1992 | 10 | 0.010 |
Why?
|
| Pyloric Stenosis | 1 | 1991 | 8 | 0.010 |
Why?
|
| Tracheostomy | 1 | 1991 | 45 | 0.010 |
Why?
|
| Animals | 2 | 1988 | 27371 | 0.010 |
Why?
|
| Dental Occlusion, Traumatic | 1 | 1989 | 1 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1994 | 2884 | 0.010 |
Why?
|
| Calcium Chloride | 1 | 1984 | 10 | 0.000 |
Why?
|
| Food, Formulated | 1 | 1984 | 24 | 0.000 |
Why?
|
| Brain | 1 | 1994 | 2285 | 0.000 |
Why?
|
| Necrosis | 1 | 1984 | 209 | 0.000 |
Why?
|
| Doxorubicin | 1 | 1984 | 301 | 0.000 |
Why?
|
| Rabbits | 1 | 1984 | 639 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1988 | 2661 | 0.000 |
Why?
|
| Time Factors | 1 | 1984 | 5338 | 0.000 |
Why?
|